Is adjuvant chemotherapy necessary for early gastric cancer?

OBJECTIVE: To quantify the potential benefit of adjuvant chemotherapy (ACT) with respect to survival, and to identify factors for predicting prognoses in early gastric cancer patients. METHODS: Patients with pT1 gastric cancer (GC) who underwent radical resection with D2 lymphadenectomy were retrosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Mei, Yu, Feng, Tienan, Yan, Min, Zhu, Zhenggang, Zhu, Zhenglun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Compuscript 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088187/
https://www.ncbi.nlm.nih.gov/pubmed/34160167
http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088187/
https://www.ncbi.nlm.nih.gov/pubmed/34160167
http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0636

Ejemplares similares